Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 3 Average LPC concentrations classified by sex and tumour diagnosis with calculation of statistically significant differences between means

From: Plasma lyso-phosphatidylcholine concentration is decreased in cancer patients with weight loss and activated inflammatory status

 

subgroup

n

average LPC conc. (μM)

standard deviation (μM)

range (μM)

significant difference*

sex

male

26

202

53

89–305

no

 

female

33

212

64

109–362

no

cancer type

breast

17

205

60

128–239

 
 

prostate

6

198

47

122–249

 
 

lung

5

177

38

118–214

no

 

lymphoma

8

227

80

98–356

 
 

gastrointestinal

12

194

53

89–270

 
 

other2

11

232

60

135–362

 
  1. 2 ovaries, kidney, bladder, uterus, mesothelioma, myeloma, aggressive fibromatosis, oligodendroglioma
  2. * p < 0.05
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X